SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001544784-24-000053
Filing Date
2024-05-09
Accepted
2024-05-09 07:02:06
Documents
72
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 6-K tmb-20240331x6k.htm 6-K 22837
2 EX-99.1 tmb-20240331xex99d1.htm   iXBRL EX-99.1 776737
3 EX-99.2 tmb-20240331xex99d2.htm EX-99.2 419859
  Complete submission text file 0001544784-24-000053.txt   3861277

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20240331.xsd EX-101.SCH 49348
5 EX-101.CAL tmb-20240331_cal.xml EX-101.CAL 42176
6 EX-101.DEF tmb-20240331_def.xml EX-101.DEF 120505
7 EX-101.LAB tmb-20240331_lab.xml EX-101.LAB 267314
8 EX-101.PRE tmb-20240331_pre.xml EX-101.PRE 217776
76 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240331xex99d1_htm.xml XML 449604
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 24928478
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)